THC Biomed Intl LtdCanadian Securities Exchange:THCView on Over The Counter Market
- LAST PRICE0.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots0.0200/ 70
- Open / Previous Close--- / 0.0200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
THC Biomed Intl Ltd | 3.3M | -0.9x | --- |
Radient Technologies Inc | 2.8M | -0.2x | --- |
Eve & Co Inc | 3.8M | -0.5x | --- |
West Island Brands Inc | 1.4M | -0.3x | --- |
Herbal Dispatch Inc | 4.9M | -2.6x | --- |
Lobe Sciences Ltd | 2.6M | -0.4x | --- |
Company Information
THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.
Contact Information
- Headquarters
- Unit 1 - 2550 AclandRoadKELOWNA, BC, Canada V1X 7L4
- Phone
- 778-753-1729
- Fax
- 250-870-2512
Executives
- President, Chief Executive Officer, Director
- John Miller
- Interim Chief Financial Officer
- Hee Jung Chun
- Independent Director
- Ashish Dave
- Independent Director
- George Smitherman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3M |
|---|---|
Revenue (TTM) | $2.9M |
Shares Outstanding | 163.9M |
THC Biomed Intl Ltd does not pay a dividend. | |
Beta | 0.45 |
EPS | $-0.02 |
Book Value | $0.04 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -126.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
